Achillion: Pipeline Update (Achillion) - May 30, 2013 - Anticipated completion of P2 trial for genotypes 2, 3, 4 treatment-naive HCV in Q2 2014; Anticipated initiation of P2 Cirrhotic trial in HCV patients with compensated cirrhosis in Q4 2013; Anticipated completion of P2 Cirrhotic trial in HCV patients compensated cirrhosis in Q4 2013; Anticipated initiation of Apollo-C P2b (sovaprevir + ACH-3102 combo) trial for genotype 1a/b tx-naive HCV patients in Q4 2013; Anticipated completion of Apollo-C P2b (sovaprevir + ACH-3102 combo) trial for genotype 1a/b tx-naive HCV patients in Q2 2014
Anticipated new P2 trial • Anticipated trial completion date • Hepatitis C Virus
|